CLINICAL_TRIALS
ClinicalTrials.gov record update
A Post-Marketing Observational Study of VYXEOS™ to Assess the Incidence of Infusion-Related Reactions in Adult Patients
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03526926
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:37.807435+00:00
- Published At
- 2020-08-05T00:00:00+00:00
- Record Updated At
- 2020-08-05
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Acute Myeloid Leukemia With Myelodysplasia-Related Changes", "Therapy-Related Acute Myeloid Leukemia"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-08-05"- protocolSection.identificationModule.nctId
"NCT03526926"- protocolSection.identificationModule.officialTitle
"A Post-Marketing Observational Study of VYXEOS\u2122 to Assess the Incidence of Infusion-Related Reactions in Adult Patients"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.